Actively Recruiting
Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity
Led by Mackay Memorial Hospital · Updated on 2025-05-09
300
Participants Needed
1
Research Sites
273 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To investigates the effects of botulinum toxin type A bladder injection compared to combined pharmacotherapy with Mirabegron and Solifenacin.
CONDITIONS
Official Title
Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with detrusor overactivity defined by involuntary detrusor contractions during bladder filling
- Patients refractory to monotherapy with either anti-muscarinics or beta-3 adrenoceptor agonists
- Female patients aged 20 to 90 years
You will not qualify if you...
- Postvoid urine retention before treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mackay Memorial Hospital
Taipei, Taiwan
Actively Recruiting
Research Team
H
Hui-Hsuan Lau, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here